{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:52:00Z","timestamp":1792547520398,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W001101\/1"],"award-info":[{"award-number":["MR\/W001101\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/15873-6"],"award-info":[{"award-number":["2019\/15873-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017727","name":"Fondazione Beretta","doi-asserted-by":"publisher","award":["MGU0468"],"award-info":[{"award-number":["MGU0468"]}],"id":[{"id":"10.13039\/100017727","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ejca.2024.114122","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T16:50:24Z","timestamp":1720025424000},"page":"114122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Adverse skeletal related events in patients with bone-metastatic pheochromocytoma\/paraganglioma"],"prefix":"10.1016","volume":"208","author":[{"given":"Marta","family":"Lagan\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouhammed Amir","family":"Habra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Remde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madson Q.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Cosentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pusceddu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara Maria","family":"Grana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora P.M.","family":"Corssmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bongiovanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"De Filpo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenie S.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Zamparini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Grisanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Deutschbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo F.C.","family":"Fagundes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Adelaide A.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Oldani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Rota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Prinzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Berruti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejca.2024.114122_bib1","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.annonc.2020.08.2099","article-title":"Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Fassnacht","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2024.114122_bib2","doi-asserted-by":"crossref","unstructured":"Moog, S., Lussey-Lepoutre C., & Favier J. Epigenetic and metabolic reprogramming of SDH-deficient paragangliomas. Endocr Relat Cancer. 27(12), R451-R463. https:\/\/doi.org\/10.1530\/ERC-20\u20130346.","DOI":"10.1530\/ERC-20-0346"},{"issue":"4","key":"10.1016\/j.ejca.2024.114122_bib3","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1210\/jc.2012-4231","article-title":"Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma","volume":"98","author":"Ayala-Ramirez","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ejca.2024.114122_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11912-022-01197-0","article-title":"New directions in treatment of metastatic or advanced pheochromocytomas and sympathetic paragangliomas: an American, contemporary, pragmatic approach","volume":"24","author":"Jimenez","year":"2022","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.ejca.2024.114122_bib5","doi-asserted-by":"crossref","unstructured":"E. Baudin, B. Goichot, A. Berruti, et al. Annals of Oncology (2021) 32 (suppl_5): S621-S625. 10.1016\/annonc\/annonc700. 567O_PR - First International Randomized Study in Malignant Progressive Pheochromocytoma and Paragangliomas (FIRSTMAPPP): An academic double-blind trial investigating sunitinib.","DOI":"10.1016\/j.annonc.2021.08.702"},{"issue":"11","key":"10.1016\/j.ejca.2024.114122_bib6","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1210\/clinem\/dgac471","volume":"107","author":"Wang","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.ejca.2024.114122_bib7","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.annonc.2020.07.019","article-title":"ESMO Guidelines Committee. Bone health in cancer: ESMO Clinical Practice Guidelines","volume":"31","author":"Coleman","year":"2020","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2024.114122_bib8","doi-asserted-by":"crossref","first-page":"e190","DOI":"10.1016\/j.clgc.2022.12.010","article-title":"Effect of Bisphosphonates on Skeletal Related Events in Long Bone Metastases of Renal Cell Carcinoma: A Systematic Review","volume":"21","author":"van Broekhoven","year":"2023","journal-title":"Clin Genitourin Cancer"},{"issue":"8","key":"10.1016\/j.ejca.2024.114122_bib9","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1093\/annonc\/mdr572","article-title":"Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study","volume":"23","author":"Santini","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2024.114122_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.588862","article-title":"High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases","volume":"10","author":"Lagan\u00e0","year":"2020","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2024.114122_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213934","article-title":"Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events","volume":"14","author":"Grisanti","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ejca.2024.114122_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/EJE-19-0026","article-title":"Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: a multicenter retrospective study","volume":"180","author":"Berruti","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejca.2024.114122_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12020-017-1455-6","article-title":"Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience","volume":"59","author":"Mazziotti","year":"2018","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.ejca.2024.114122_bib14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/sj.bjc.6602767","article-title":"Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease","volume":"93","author":"Berruti","year":"2005","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2024.114122_bib15","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.eururo.2015.04.032","article-title":"Impact of bone-targeted therapies in chemotherapy-na\u00efve metastatic castration-resistant prostate cancer patients treated with abiraterone acetate: post hoc analysis of study COU-AA-302","volume":"68","author":"Saad","year":"2015","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ejca.2024.114122_bib16","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41391-018-0055-8","article-title":"Addition of abiraterone, docetaxel, bisphosphonate, celecoxib or combinations to androgen-deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer (mHSPC): a network meta-analysis","volume":"21","author":"Tan","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804924007780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804924007780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:53:17Z","timestamp":1778568797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804924007780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":16,"alternative-id":["S0959804924007780"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2024.114122","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse skeletal related events in patients with bone-metastatic pheochromocytoma\/paraganglioma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2024.114122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"114122"}}